Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Dumas (Villejuif, France). Cleaning agents and chronic lung disease: does the evidence support a link with COPD?. International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?

Member's Comments

No comment yet.

Related content which might interest you: Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice Source: Eur Respir J, 54 (3) 1901363; 10.1183/13993003.01363-2019 Year: 2019 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Chronic bronchitis, COPD and lung function in Norwegian farmers: the role of biological agents Source: Eur Respir J 2006; 28: Suppl. 50, 146s Year: 2006 Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice Source: Eur Respir J 2013; 41: 1252-1256 Year: 2013 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 What factors influence adherence to portable oxygen systems in patients with chronic obstructive pulmonary disease (COPD)? A qualitative study Source: Annual Congress 2008 - Respiratory mechanics, muscles and breathing; functional status measures and coping styles Year: 2008 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Initial diagnosis of COPD: the role of primary care and when to refer Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006 Programme organisation: what and how can we do better? Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines Year: 2007 Is there a strong relationship between COPD and cardiovascular diseases? Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013